REDMILE GROUP, LLC sold 36.4% of their position (5.88M shares) of ADC THERAPEUTICS SA on the open market
Open‑market sale worth $19.64M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 6 sales
Filed: 4/2/2026ACC: 0001104659-26-039359
-5.88M
Net shares
Net seller
$19.64M
Total sold
6
Open market trades
0B · 6S
6
Total transactions
5.88M disposed
Non-Derivative Transactions6
Common Stock
Indirect
Shares
−196.23K
Price / share
$3.75
Trade value
$736.25K
% of position
1.3%
3/31/2026
15.67M→15.47M
Common Stock
Direct
Shares
−188.41K
Price / share
$3.75
Trade value
$706.90K
% of position
1.4%
3/31/2026
13.15M→12.96M
Common Stock
Indirect
Shares
−169.26K
Price / share
$3.80
Trade value
$643.04K
% of position
1.1%
4/1/2026
15.47M→15.30M
Common Stock
Direct
Shares
−162.52K
Price / share
$3.80
Trade value
$617.40K
% of position
1.3%
4/1/2026
12.96M→12.79M
Common Stock
Indirect
Shares
−2.63M
Price / share
$3.28
Trade value
$8.64M
% of position
17.2%
4/2/2026
15.30M→12.67M
Common Stock
Direct
Shares
−2.53M
Price / share
$3.28
Trade value
$8.29M
% of position
19.8%
4/2/2026
12.79M→10.27M
Total
Net shares
−5.88M
Net value
-$19.64M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/31/2026 | S · Sale | −196.23K | $3.75 | $736.25K | 1.3% | 15.67M | 15.47M |
| Common Stock Direct | 3/31/2026 | S · Sale | −188.41K | $3.75 | $706.90K | 1.4% | 13.15M | 12.96M |
| Common Stock Indirect | 4/1/2026 | S · Sale | −169.26K | $3.80 | $643.04K | 1.1% | 15.47M | 15.30M |
| Common Stock Direct | 4/1/2026 | S · Sale | −162.52K | $3.80 | $617.40K | 1.3% | 12.96M | 12.79M |
| Common Stock Indirect | 4/2/2026 | S · Sale | −2.63M | $3.28 | $8.64M | 17.2% | 15.30M | 12.67M |
| Common Stock Direct | 4/2/2026 | S · Sale | −2.53M | $3.28 | $8.29M | 19.8% | 12.79M | 10.27M |
| Total | −5.88M | -$19.64M | ||||||
Derivative Transactions0
No derivative transactions reported